Nordic study aims to settle debate on best Clot-Busting approach for lung embolism
NCT ID NCT07003646
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 220 adults across Nordic countries who receive either clot-dissolving drugs or a catheter-based procedure for a severe pulmonary embolism. Researchers are comparing how often each treatment leads to serious bleeding or death within 30 days. The goal is to provide real-world evidence on which approach is safer and more effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Alteplase
- What this could lead to
- If successful, this study could clarify which reperfusion method is safer and more effective for high-risk pulmonary embolism, guiding future treatment guidelines.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be influenced by patient selection and cannot prove cause and effect. The small size (220 participants) limits generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Denmark
-
Danderyd Hospital
RECRUITINGStockholm, Sweden
-
Karolinska University Hospital Huddinge
RECRUITINGStockholm, Sweden
-
Karolinska University Hospital Solna
RECRUITINGStockholm, Sweden
-
Linköping University Hospital
RECRUITINGLinköping, Sweden
-
Odense University Hospital
RECRUITINGOdense, Denmark
-
Rigshospitalet
RECRUITINGCopenhagen, Denmark
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, 41345, Sweden
-
Skåne University Hospital
RECRUITINGLund, Sweden
-
Sunderby Hospital
RECRUITINGLuleå, Sweden
-
Södersjukhuset
RECRUITINGStockholm, Sweden
-
Uppsala University Hospital
NOT_YET_RECRUITINGUppsala, Sweden
-
Örebro University Hospital
RECRUITINGÖrebro, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new exercise plan aims to get pulmonary embolism survivors back on their feet
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Massive chest pain registry reveals gaps between guidelines and real-world care in china
- New catheter aims to treat dangerous blood clots in the lungs without ICU stay
- Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm